Jon S Odorico, MD
Professor
- Section of Kidney and Pancreas Surgery
- Division of Transplantation
jon@surgery.wisc.edu
(608) 263-0388
Clinical Science Center
600 Highland Avenue
Madison WI 53792
Education
- MD, New York University, School of Medicine, New York, NY, 1987
- Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1987-1994
- Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA, 1990-1992
- Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1994-1996
Honors
Best Doctors in America Award Surgery, Transplantation
Madison Magazine Top Docs 2012 Award Surgery, Transplantation
Clinical Specialties
Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.
Dr. Odorico provides a wide range of services including Kidney Transplant, Pancreas Transplant.
Research Interests
Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab
Clinical Trials
Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
10/18/2018 –present
Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020
Recent Publications
The Presence of Donor-specific Antibodies Around the Time of Pancreas Graft Biopsy With Rejection Is Associated With an Increased Risk of Graft Failure.
Parajuli S, Djamali A, Mandelbrot D, Aziz F, Radke N, Kaufman D, Odorico J
Transplantation 2022 Apr 14;
[PubMed ID: 35427295]Utility of Protocol Pancreas Biopsies for De Novo Donor-specific Antibodies.
Parajuli S, Mandelbrot D, Odorico J
Transplant Direct 2022 Mar; 8(3): e1287
[PubMed ID: 35187214]International Survey of Clinical Monitoring Practices in Pancreas and Islet Transplantation.
Ward C, Odorico JS, Rickels MR, Berney T, Burke GW, Kay TWH, Thaunat O, Uva PD, de Koning EJP, Arbogast H, Scholz H, Cattral MS, Stratta RJ, Stock PG, International Pancreas and Islet Transplant Association Beta-Cell Replacement Therapy Monitoring Task Force
Transplantation 2022 01 10;
[PubMed ID: 35019897]Intracameral Microimaging of Maturation of Human iPSC Derivatives into Islet Endocrine Cells.
Zhao K, Shi Y, Yu J, Yu L, Mael A, Li Y, Kolton A, Joyce T, Odorico J, Berggren PO, Yang SN
Cell Transplant 2022 Jan-Dec; 31: 9636897211066508
[PubMed ID: 35156411]P.148: Post-Pancreatic Transplant Enteric Leaks: The Role of the Salvage Operation.
Fleetwood V, Falls C, Ohman J, Aziz A, Stalter L, Leverson G, Welch B, Kaufman D, Al-Adra D, Odorico JS
Transplantation 2021 Dec 01; 105(12 Suppl 2): S61
[PubMed ID: 34908276]